160 related articles for article (PubMed ID: 36435920)
21. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
22. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
23. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
Ren K; Yu Y; Wang X; Liu H; Zhao J
Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
[TBL] [Abstract][Full Text] [Related]
24. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
25. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
27. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
[TBL] [Abstract][Full Text] [Related]
28. EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling.
Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
[TBL] [Abstract][Full Text] [Related]
29. Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10.
Yuan C; Bai R; Gao Y; Jiang X; Li S; Sun W; Li Y; Huang Z; Gong Y; Xie C
Oxid Med Cell Longev; 2021; 2021():4522210. PubMed ID: 34925694
[TBL] [Abstract][Full Text] [Related]
30. Identification of LBX2 as a novel causal gene of lung adenocarcinoma.
Hu J; Bai Y; Zhang Q; Li M; Yin R; Xu L
Thorac Cancer; 2020 Aug; 11(8):2137-2145. PubMed ID: 32567804
[TBL] [Abstract][Full Text] [Related]
31. Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
Gantenbein N; Bernhart E; Anders I; Golob-Schwarzl N; Krassnig S; Wodlej C; Brcic L; Lindenmann J; Fink-Neuboeck N; Gollowitsch F; Stacher-Priehse E; Asslaber M; Gogg-Kamerer M; Rolff J; Hoffmann J; Silvestri A; Regenbrecht C; Reinhard C; Pehserl AM; Pichler M; Sokolova O; Naumann M; Mitterer V; Pertschy B; Bergler H; Popper H; Sattler W; Haybaeck J
Eur J Cancer; 2018 Sep; 101():165-180. PubMed ID: 30077122
[TBL] [Abstract][Full Text] [Related]
32. DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.
Chen M; Zhang S; Wang F; He J; Jiang W; Zhang L
J Transl Med; 2024 Feb; 22(1):209. PubMed ID: 38414025
[TBL] [Abstract][Full Text] [Related]
33. JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma.
Dong Y; Zhang J; Xie S; Di S; Fan B; Gong T
J Gene Med; 2024 Feb; 26(2):e3679. PubMed ID: 38404047
[TBL] [Abstract][Full Text] [Related]
34. High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma.
Fei W; Yan Y; Liu G; Peng B; Liu Y; Chen Q
PeerJ; 2023; 11():e16306. PubMed ID: 37904848
[TBL] [Abstract][Full Text] [Related]
35. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
[TBL] [Abstract][Full Text] [Related]
36. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
37. MicroRNA-106b-5p inhibits growth and progression of lung adenocarcinoma cells by downregulating IGSF10.
Ling B; Liao X; Tang Q; Ye G; Bin X; Wang J; Pang Y; Qi G
Aging (Albany NY); 2021 Jul; 13(14):18740-18756. PubMed ID: 34351868
[TBL] [Abstract][Full Text] [Related]
38. EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma.
Zhao W; Liu L; Li X; Xu S
Int Immunopharmacol; 2022 Sep; 110():109031. PubMed ID: 35839564
[TBL] [Abstract][Full Text] [Related]
39. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
Golob-Schwarzl N; Wodlej C; Kleinegger F; Gogg-Kamerer M; Birkl-Toeglhofer AM; Petzold J; Aigelsreiter A; Thalhammer M; Park YN; Haybaeck J
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2699-2711. PubMed ID: 31586263
[TBL] [Abstract][Full Text] [Related]
40. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
